Stephen W. Sun, M.D., M.PH. has been named chief medical officer at ParagonRx, an inVentiv Health company. He will advise clients on regulatory and safety issues and will report directly to ParagonRx president Jeffrey Fetterman. “The focus today is on enhanced pharmacovigilance, putting preventions in place before any regulatory body requires it,” said Mr. Fetterman. “Dr. Sun’s FDA experience will enrich the guidance we offer clients to assure that active risk management...